Loading clinical trials...
Loading clinical trials...
Substantial variability exists in the onset, and rate of degeneration across individuals with Motor Neurone Disease (MND) or Amyotrophic Lateral Sclerosis (ALS). This variability requires biomarkers t...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University of Dublin, Trinity College
Collaborators
NCT05204017 · Amyotrophic Lateral Sclerosis, Primary Lateral Sclerosis, and more
NCT07233148 · Amyotrophic Lateral Sclerosis (ALS), Motor Neuron Disease (MND), and more
NCT07187388 · Amyotrophic Lateral Sclerosis (ALS), Primary Lateral Sclerosis (PLS), and more
NCT02567136 · Amyotrophic Lateral Sclerosis, Primary Lateral Sclerosis
NCT03489278 · Amyotrophic Lateral Sclerosis, ALS-Frontotemporal Dementia, and more
Academic Unit of Neurology, Trinity College Dublin, The University of Dublin
Dublin, Leinster
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions